An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)

University Hospital Southampton NHS Foundation Trust /ID# 258989, Southampton

Guys and St Thomas NHS Foundation Trust /ID# 258986, London

NHS Lothian /ID# 260901, Edinburgh

The Royal London Hospital /ID# 259047, London

The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 260902, Newcastle upon Tyne